Literature DB >> 19714496

Is platelet activity important in acute intracerebral hemorrhage?

Christine A C Wijman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19714496     DOI： 10.1007/s12028-009-9271-3

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  15 in total

1.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

Authors:  S M Davis; J Broderick; M Hennerici; N C Brun; M N Diringer; S A Mayer; K Begtrup; T Steiner
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death.

Authors:  Pertti Saloheimo; Mikko Ahonen; Seppo Juvela; Juhani Pyhtinen; Eeva-Riitta Savolainen; Matti Hillbom
Journal:  Stroke       Date:  2005-12-01       Impact factor: 7.914

3.  Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.

Authors:  Christian Foerch; Matthias Sitzer; Helmuth Steinmetz; Tobias Neumann-Haefelin
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

4.  Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.

Authors:  Jaume Roquer; Ana Rodríguez Campello; Meritxell Gomis; Angel Ois; Victor Puente; Elvira Munteis
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

5.  Early hemorrhage growth in patients with intracerebral hemorrhage.

Authors:  T Brott; J Broderick; R Kothari; W Barsan; T Tomsick; L Sauerbeck; J Spilker; J Duldner; J Khoury
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

6.  CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage.

Authors:  Ryan Wada; Richard I Aviv; Allan J Fox; Demetrios J Sahlas; David J Gladstone; George Tomlinson; Sean P Symons
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

7.  Determinants of intracerebral hemorrhage growth: an exploratory analysis.

Authors:  Joseph P Broderick; Michael N Diringer; Michael D Hill; Nikolai C Brun; Stephan A Mayer; Thorsten Steiner; Brett E Skolnick; Stephen M Davis
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

8.  Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage.

Authors:  Y Fujii; S Takeuchi; O Sasaki; T Minakawa; R Tanaka
Journal:  Stroke       Date:  1998-06       Impact factor: 7.914

9.  Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.

Authors:  Andrew M Naidech; Sarice L Bassin; Richard A Bernstein; H Hunt Batjer; Mark J Alberts; Paul F Lindholm; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

10.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

Authors:  Craig S Anderson; Yining Huang; Ji Guang Wang; Hisatomi Arima; Bruce Neal; Bin Peng; Emma Heeley; Christian Skulina; Mark W Parsons; Jong Sung Kim; Qing Ling Tao; Yue Chun Li; Jian Dong Jiang; Li Wen Tai; Jin Li Zhang; En Xu; Yan Cheng; Stephane Heritier; Lewis B Morgenstern; John Chalmers
Journal:  Lancet Neurol       Date:  2008-04-07       Impact factor: 44.182
View more
  2 in total

1.  Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage.

Authors:  Arne Lauer; Frieder Schlunk; Elizabeth M Van Cott; Helmuth Steinmetz; Eng H Lo; Christian Foerch
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

2.  Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.

Authors:  Toshinori Takagi; Takahiko Imai; Keisuke Mishiro; Mitsue Ishisaka; Masanori Tsujimoto; Hideki Ito; Kazunori Nagashima; Haruka Matsukawa; Kazuhiro Tsuruma; Masamitsu Shimazawa; Shinichi Yoshimura; Osamu Kozawa; Toru Iwama; Hideaki Hara
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-01       Impact factor: 6.200
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.